跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,064 条关于
“hypothalamic inflammation”
全部
8,064
临床试验
4,802
药物
130
机构
17
资讯
3,115
3个月前
Gut Microbes May Explain Why Obesity and Type 2 Diabetes Become Harder to Reverse
去年
NodThera's NLRP3 Inhibitor NT-0796 Shows Enhanced Weight Loss When Combined with GLP-1 Therapy
去年
Setmelanotide Receives Orphan Drug Designation in Japan for Hypothalamic Obesity Treatment
去年
Rhythm's Imcivree Shows Significant Weight Loss in Patients with Hypothalamic Obesity
去年
Rhythm Pharmaceuticals' Setmelanotide Shows Breakthrough Results in Rare Hypothalamic Obesity Trial
7个月前
Regeneron Advances Phase 2 Trial of Mibavademab for Functional Hypothalamic Amenorrhea
去年
Rhythm Pharmaceuticals' Imcivree Shows Significant Weight Loss in Phase III Hypothalamic Obesity Trial
8个月前
Rhythm Pharmaceuticals Faces FDA Delay for Setmelanotide in Hypothalamic Obesity as Stock Retreats from 2025 Highs
去年
Rhythm Pharmaceuticals Reports Strong Q3 2024 Driven by IMCIVREE Sales, Advances Hypothalamic Obesity Program
去年
Implantable Sensor Provides Real-Time Monitoring of Inflammation
第 1 页,共 312 页
上一页
下一页